A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps ...

Human Melanoma Metastasis in NSG Mice Correlates with Clinical Outcome in Patients. Science Translational Medicine , 2012 DOI: 10.1126/scitranslmed.3004599 Cite This Page : ...

Spread of human melanoma cells in mice correlates with clinical outcomes in patients Peer-Reviewed Publication. UT Southwestern Medical Center ...

In other tests, the team injected mice with melanoma cells then followed it up with a series of five injections of Rb4 over 10 days. Tumor growth was delayed by up to 40 days in the treated mice ...

Mice with melanoma tumors were treated 10 days after tumor initiation with either a control drug, the checkpoint inhibitor, s-DAB-IL-2 or s-DAB-IL-2(V6A) as solo therapies.

Institut Curie researchers have identified a sex-specific molecular pathway connecting E-cadherin loss, estrogen receptor-α ...

Researchers investigated melanoma-induced tumor growth in the bones of mice treated with gut microbiome-depleting antibiotics. They found that the number of bone tumor cells was greater in ...

There are several factors that actively drive melanoma progression including MET, a tyrosine kinase receptor overexpressed in melanoma and implicated in tumor growth, invasion, and drug resistance.

If those surface molecules are indeed what enable melanoma to spread to the lymph nodes (stage 3 cancer) and beyond (stage 4), then blocking them might prevent metastasis.In fact, when scientists ...

The team developed an IgE antibody specific for a marker on the surface of human melanoma cells, called chondroitin sulfate proteoglycan 4 (CSPG4) found on up to 70% of melanomas.

In mice with ocular melanoma, no visible residual tumor was left after they were submitted to photodynamic therapy with Visudyne, a drug used to treat macular degeneration.